Actively Recruiting
Hypnosis: a Path to Appeasement in Hematologic Cancer Patients with Anxiety
Led by Hospices Civils de Lyon · Updated on 2025-09-11
50
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of hypnosis as a method to help patients manage anxiety related to hematologic cancers, specifically diffuse large cell B-cell lymphoma or follicular lymphoma. Hypnosis is a technique that focuses mental attention to reduce negative feelings or distress, and while it has shown benefits in breast cancer patients, its effect on anxiety in hematology patients has not been thoroughly studied. Participants will undergo hypnotherapy sessions, with anxiety measured before the first session, just before the third session, and after the third session via telephone consultation. The study observes the evolution of anxiety over time, including assessments at 6 weeks and 3 months after starting hypnotherapy. During the study, patients will complete anxiety questionnaires and attend hypnotherapy sessions as scheduled. Researchers will track changes in anxiety scores using the Hospital Anxiety and Depression Scale (HADS). The main outcome is the anxiety level at 6 weeks after two hypnosis sessions, with additional follow-ups at 3 months to observe longer-term effects. The trial duration and participation involve these scheduled assessments and therapy sessions.
CONDITIONS
Brief Title
Hypnosis: a Path to Appeasement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years old, fluent in French
- Patients starting hypnotherapy for anxiety disorders
- Anxiety score on the Hospital Anxiety and Depression Scale (HADS) of 8 or higher
- Patients diagnosed with diffuse large cell B-cell lymphoma or follicular lymphoma, any disease stage
- Diagnosis announced less than 2 months ago
You will not qualify if you...
- Persons deprived of their liberty by judicial or administrative decision
- Adults under legal protection measures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - 6 weeks
Participants receive hypnotherapy sessions to manage anxiety.
2 hypnosis sessions over 6 weeks with anxiety assessments before the third session
Duration - 3 months
Participants are followed for an additional 3 months after hypnotherapy to monitor anxiety levels.
1 telephonic consultation after 3 months
Trial Site Locations
Total: 1 location
1
Service MB1 - Hôpital Lyon Sud - HCL
Lyon, Pierre-Bénite, France, 69495
Actively Recruiting
Research Team
T
Thomas BERT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here